Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 4 | 2024 | 142 | 2.410 |
Why?
|
| Burns | 5 | 2019 | 170 | 1.660 |
Why?
|
| Body Composition | 3 | 2019 | 349 | 1.200 |
Why?
|
| Body Mass Index | 6 | 2024 | 713 | 1.150 |
Why?
|
| Weight Gain | 3 | 2022 | 243 | 0.970 |
Why?
|
| Muscle Proteins | 3 | 2015 | 307 | 0.940 |
Why?
|
| Homeostasis | 2 | 2021 | 223 | 0.810 |
Why?
|
| Leptin | 1 | 2022 | 154 | 0.780 |
Why?
|
| Muscle, Skeletal | 4 | 2019 | 847 | 0.760 |
Why?
|
| Obesity | 4 | 2024 | 1202 | 0.750 |
Why?
|
| Breast Feeding | 1 | 2022 | 189 | 0.740 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 59 | 0.740 |
Why?
|
| Triglycerides | 2 | 2020 | 195 | 0.740 |
Why?
|
| Adiponectin | 1 | 2020 | 76 | 0.730 |
Why?
|
| Blood Glucose | 3 | 2019 | 489 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 202 | 0.730 |
Why?
|
| Liver | 3 | 2022 | 1225 | 0.700 |
Why?
|
| Blood Pressure | 2 | 2021 | 587 | 0.680 |
Why?
|
| Indocyanine Green | 1 | 2019 | 39 | 0.680 |
Why?
|
| Insulin Resistance | 4 | 2021 | 300 | 0.620 |
Why?
|
| Adipose Tissue | 1 | 2019 | 207 | 0.610 |
Why?
|
| Child | 9 | 2024 | 7341 | 0.590 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2014 | 105 | 0.590 |
Why?
|
| Child, Preschool | 9 | 2024 | 4147 | 0.580 |
Why?
|
| Parents | 1 | 2019 | 344 | 0.570 |
Why?
|
| Pregnancy | 7 | 2024 | 2620 | 0.550 |
Why?
|
| Anabolic Agents | 1 | 2014 | 35 | 0.500 |
Why?
|
| Androgens | 1 | 2014 | 68 | 0.500 |
Why?
|
| Insulin | 4 | 2022 | 510 | 0.460 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 177 | 0.450 |
Why?
|
| Female | 15 | 2024 | 28441 | 0.410 |
Why?
|
| Male | 11 | 2024 | 27334 | 0.350 |
Why?
|
| Oxygen Consumption | 2 | 2021 | 223 | 0.350 |
Why?
|
| Humans | 17 | 2024 | 54284 | 0.340 |
Why?
|
| Dietary Proteins | 2 | 2021 | 230 | 0.310 |
Why?
|
| Anthropometry | 1 | 2024 | 96 | 0.240 |
Why?
|
| Propranolol | 2 | 2014 | 78 | 0.230 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 42 | 0.220 |
Why?
|
| Palmitates | 1 | 2022 | 28 | 0.220 |
Why?
|
| Exercise | 2 | 2024 | 552 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 138 | 0.200 |
Why?
|
| Alanine Transaminase | 1 | 2021 | 151 | 0.200 |
Why?
|
| Gestational Age | 2 | 2019 | 435 | 0.200 |
Why?
|
| Nutrition Policy | 1 | 2021 | 52 | 0.190 |
Why?
|
| Nutritional Requirements | 1 | 2021 | 69 | 0.190 |
Why?
|
| Adolescent | 4 | 2021 | 6897 | 0.190 |
Why?
|
| Lipids | 1 | 2021 | 178 | 0.190 |
Why?
|
| Eating | 1 | 2021 | 155 | 0.190 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2020 | 44 | 0.180 |
Why?
|
| Burn Units | 1 | 2019 | 9 | 0.180 |
Why?
|
| Liver Failure | 1 | 2019 | 27 | 0.170 |
Why?
|
| Plethysmography | 1 | 2019 | 45 | 0.170 |
Why?
|
| Blood Cells | 1 | 2019 | 58 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 137 | 0.170 |
Why?
|
| Adult | 6 | 2020 | 14207 | 0.170 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 51 | 0.170 |
Why?
|
| Mitochondria, Muscle | 1 | 2019 | 46 | 0.170 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 54 | 0.170 |
Why?
|
| Organ Size | 1 | 2019 | 237 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2019 | 78 | 0.160 |
Why?
|
| Infant | 4 | 2021 | 3817 | 0.160 |
Why?
|
| Hepatocytes | 1 | 2019 | 214 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1693 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 746 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2019 | 353 | 0.140 |
Why?
|
| Hypertension | 1 | 2021 | 564 | 0.140 |
Why?
|
| Amino Acids | 2 | 2021 | 369 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2387 | 0.130 |
Why?
|
| Age Factors | 1 | 2019 | 1198 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2020 | 2907 | 0.130 |
Why?
|
| Nutritional Support | 1 | 2015 | 35 | 0.130 |
Why?
|
| Oxandrolone | 1 | 2014 | 10 | 0.130 |
Why?
|
| Body Surface Area | 1 | 2014 | 25 | 0.130 |
Why?
|
| Human Growth Hormone | 1 | 2014 | 51 | 0.120 |
Why?
|
| Testosterone | 1 | 2014 | 119 | 0.120 |
Why?
|
| Time Factors | 2 | 2019 | 3213 | 0.120 |
Why?
|
| Metformin | 1 | 2014 | 66 | 0.120 |
Why?
|
| Prognosis | 1 | 2019 | 2118 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 1604 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 569 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1048 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2015 | 2604 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2014 | 5604 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2020 | 1543 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2019 | 311 | 0.060 |
Why?
|
| Nitrogen | 1 | 2021 | 78 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 382 | 0.040 |
Why?
|
| Oxidative Phosphorylation Coupling Factors | 1 | 2019 | 8 | 0.040 |
Why?
|
| Monocytes | 1 | 2019 | 156 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1304 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2019 | 269 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1228 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 823 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2012 | 29 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 231 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 401 | 0.030 |
Why?
|
| Heart Rate | 1 | 2012 | 357 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 3935 | 0.020 |
Why?
|